Pharma & Healthcare

Global Plasmid DNA CDMO Market Research Report 2025

The global market for Plasmid DNA CDMO was valued at US$ 241 million in the year 2024 and is projected to reach a revised size of US$ 953 million by 2031, growing at a CAGR of 22.0% during the forecast period.
North American market for Plasmid DNA CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Plasmid DNA CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Plasmid DNA CDMO in DNA Vaccines is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Plasmid DNA CDMO include GenScript ProBio, Biovian, Biomay, VGXI, Esco Aster, Catalent, Richter-Helm BioLogics, Cytovance Biologics, Cobra Biologics, Obiosh, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Plasmid DNA CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasmid DNA CDMO.
The Plasmid DNA CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Plasmid DNA CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Plasmid DNA CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GenScript ProBio
Biovian
Biomay
VGXI
Esco Aster
Catalent
Richter-Helm BioLogics
Cytovance Biologics
Cobra Biologics
Obiosh
Thermo Fisher
Aldevron(Danaher)
Charles River Laboratories
WuXi AppTec
AGC Biologics
AcuraBio
GENE Chem
Eurogentec
PlasmidFactory
Segment by Type
GMP Grade Plasmid DNA
Non-GMP Grade Plasmid DNA
Segment by Application
DNA Vaccines
Gene Therapy
Immunotherapy
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Plasmid DNA CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plasmid DNA CDMO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 GMP Grade Plasmid DNA
1.2.3 Non-GMP Grade Plasmid DNA
1.3 Market by Application
1.3.1 Global Plasmid DNA CDMO Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 DNA Vaccines
1.3.3 Gene Therapy
1.3.4 Immunotherapy
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Plasmid DNA CDMO Market Perspective (2020-2031)
2.2 Global Plasmid DNA CDMO Growth Trends by Region
2.2.1 Global Plasmid DNA CDMO Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Plasmid DNA CDMO Historic Market Size by Region (2020-2025)
2.2.3 Plasmid DNA CDMO Forecasted Market Size by Region (2026-2031)
2.3 Plasmid DNA CDMO Market Dynamics
2.3.1 Plasmid DNA CDMO Industry Trends
2.3.2 Plasmid DNA CDMO Market Drivers
2.3.3 Plasmid DNA CDMO Market Challenges
2.3.4 Plasmid DNA CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Plasmid DNA CDMO Players by Revenue
3.1.1 Global Top Plasmid DNA CDMO Players by Revenue (2020-2025)
3.1.2 Global Plasmid DNA CDMO Revenue Market Share by Players (2020-2025)
3.2 Global Plasmid DNA CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Plasmid DNA CDMO Revenue
3.4 Global Plasmid DNA CDMO Market Concentration Ratio
3.4.1 Global Plasmid DNA CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plasmid DNA CDMO Revenue in 2024
3.5 Global Key Players of Plasmid DNA CDMO Head office and Area Served
3.6 Global Key Players of Plasmid DNA CDMO, Product and Application
3.7 Global Key Players of Plasmid DNA CDMO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Plasmid DNA CDMO Breakdown Data by Type
4.1 Global Plasmid DNA CDMO Historic Market Size by Type (2020-2025)
4.2 Global Plasmid DNA CDMO Forecasted Market Size by Type (2026-2031)
5 Plasmid DNA CDMO Breakdown Data by Application
5.1 Global Plasmid DNA CDMO Historic Market Size by Application (2020-2025)
5.2 Global Plasmid DNA CDMO Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Plasmid DNA CDMO Market Size (2020-2031)
6.2 North America Plasmid DNA CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Plasmid DNA CDMO Market Size by Country (2020-2025)
6.4 North America Plasmid DNA CDMO Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Plasmid DNA CDMO Market Size (2020-2031)
7.2 Europe Plasmid DNA CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Plasmid DNA CDMO Market Size by Country (2020-2025)
7.4 Europe Plasmid DNA CDMO Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Plasmid DNA CDMO Market Size (2020-2031)
8.2 Asia-Pacific Plasmid DNA CDMO Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Plasmid DNA CDMO Market Size by Region (2020-2025)
8.4 Asia-Pacific Plasmid DNA CDMO Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Plasmid DNA CDMO Market Size (2020-2031)
9.2 Latin America Plasmid DNA CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Plasmid DNA CDMO Market Size by Country (2020-2025)
9.4 Latin America Plasmid DNA CDMO Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Plasmid DNA CDMO Market Size (2020-2031)
10.2 Middle East & Africa Plasmid DNA CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Plasmid DNA CDMO Market Size by Country (2020-2025)
10.4 Middle East & Africa Plasmid DNA CDMO Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GenScript ProBio
11.1.1 GenScript ProBio Company Details
11.1.2 GenScript ProBio Business Overview
11.1.3 GenScript ProBio Plasmid DNA CDMO Introduction
11.1.4 GenScript ProBio Revenue in Plasmid DNA CDMO Business (2020-2025)
11.1.5 GenScript ProBio Recent Development
11.2 Biovian
11.2.1 Biovian Company Details
11.2.2 Biovian Business Overview
11.2.3 Biovian Plasmid DNA CDMO Introduction
11.2.4 Biovian Revenue in Plasmid DNA CDMO Business (2020-2025)
11.2.5 Biovian Recent Development
11.3 Biomay
11.3.1 Biomay Company Details
11.3.2 Biomay Business Overview
11.3.3 Biomay Plasmid DNA CDMO Introduction
11.3.4 Biomay Revenue in Plasmid DNA CDMO Business (2020-2025)
11.3.5 Biomay Recent Development
11.4 VGXI
11.4.1 VGXI Company Details
11.4.2 VGXI Business Overview
11.4.3 VGXI Plasmid DNA CDMO Introduction
11.4.4 VGXI Revenue in Plasmid DNA CDMO Business (2020-2025)
11.4.5 VGXI Recent Development
11.5 Esco Aster
11.5.1 Esco Aster Company Details
11.5.2 Esco Aster Business Overview
11.5.3 Esco Aster Plasmid DNA CDMO Introduction
11.5.4 Esco Aster Revenue in Plasmid DNA CDMO Business (2020-2025)
11.5.5 Esco Aster Recent Development
11.6 Catalent
11.6.1 Catalent Company Details
11.6.2 Catalent Business Overview
11.6.3 Catalent Plasmid DNA CDMO Introduction
11.6.4 Catalent Revenue in Plasmid DNA CDMO Business (2020-2025)
11.6.5 Catalent Recent Development
11.7 Richter-Helm BioLogics
11.7.1 Richter-Helm BioLogics Company Details
11.7.2 Richter-Helm BioLogics Business Overview
11.7.3 Richter-Helm BioLogics Plasmid DNA CDMO Introduction
11.7.4 Richter-Helm BioLogics Revenue in Plasmid DNA CDMO Business (2020-2025)
11.7.5 Richter-Helm BioLogics Recent Development
11.8 Cytovance Biologics
11.8.1 Cytovance Biologics Company Details
11.8.2 Cytovance Biologics Business Overview
11.8.3 Cytovance Biologics Plasmid DNA CDMO Introduction
11.8.4 Cytovance Biologics Revenue in Plasmid DNA CDMO Business (2020-2025)
11.8.5 Cytovance Biologics Recent Development
11.9 Cobra Biologics
11.9.1 Cobra Biologics Company Details
11.9.2 Cobra Biologics Business Overview
11.9.3 Cobra Biologics Plasmid DNA CDMO Introduction
11.9.4 Cobra Biologics Revenue in Plasmid DNA CDMO Business (2020-2025)
11.9.5 Cobra Biologics Recent Development
11.10 Obiosh
11.10.1 Obiosh Company Details
11.10.2 Obiosh Business Overview
11.10.3 Obiosh Plasmid DNA CDMO Introduction
11.10.4 Obiosh Revenue in Plasmid DNA CDMO Business (2020-2025)
11.10.5 Obiosh Recent Development
11.11 Thermo Fisher
11.11.1 Thermo Fisher Company Details
11.11.2 Thermo Fisher Business Overview
11.11.3 Thermo Fisher Plasmid DNA CDMO Introduction
11.11.4 Thermo Fisher Revenue in Plasmid DNA CDMO Business (2020-2025)
11.11.5 Thermo Fisher Recent Development
11.12 Aldevron(Danaher)
11.12.1 Aldevron(Danaher) Company Details
11.12.2 Aldevron(Danaher) Business Overview
11.12.3 Aldevron(Danaher) Plasmid DNA CDMO Introduction
11.12.4 Aldevron(Danaher) Revenue in Plasmid DNA CDMO Business (2020-2025)
11.12.5 Aldevron(Danaher) Recent Development
11.13 Charles River Laboratories
11.13.1 Charles River Laboratories Company Details
11.13.2 Charles River Laboratories Business Overview
11.13.3 Charles River Laboratories Plasmid DNA CDMO Introduction
11.13.4 Charles River Laboratories Revenue in Plasmid DNA CDMO Business (2020-2025)
11.13.5 Charles River Laboratories Recent Development
11.14 WuXi AppTec
11.14.1 WuXi AppTec Company Details
11.14.2 WuXi AppTec Business Overview
11.14.3 WuXi AppTec Plasmid DNA CDMO Introduction
11.14.4 WuXi AppTec Revenue in Plasmid DNA CDMO Business (2020-2025)
11.14.5 WuXi AppTec Recent Development
11.15 AGC Biologics
11.15.1 AGC Biologics Company Details
11.15.2 AGC Biologics Business Overview
11.15.3 AGC Biologics Plasmid DNA CDMO Introduction
11.15.4 AGC Biologics Revenue in Plasmid DNA CDMO Business (2020-2025)
11.15.5 AGC Biologics Recent Development
11.16 AcuraBio
11.16.1 AcuraBio Company Details
11.16.2 AcuraBio Business Overview
11.16.3 AcuraBio Plasmid DNA CDMO Introduction
11.16.4 AcuraBio Revenue in Plasmid DNA CDMO Business (2020-2025)
11.16.5 AcuraBio Recent Development
11.17 GENE Chem
11.17.1 GENE Chem Company Details
11.17.2 GENE Chem Business Overview
11.17.3 GENE Chem Plasmid DNA CDMO Introduction
11.17.4 GENE Chem Revenue in Plasmid DNA CDMO Business (2020-2025)
11.17.5 GENE Chem Recent Development
11.18 Eurogentec
11.18.1 Eurogentec Company Details
11.18.2 Eurogentec Business Overview
11.18.3 Eurogentec Plasmid DNA CDMO Introduction
11.18.4 Eurogentec Revenue in Plasmid DNA CDMO Business (2020-2025)
11.18.5 Eurogentec Recent Development
11.19 PlasmidFactory
11.19.1 PlasmidFactory Company Details
11.19.2 PlasmidFactory Business Overview
11.19.3 PlasmidFactory Plasmid DNA CDMO Introduction
11.19.4 PlasmidFactory Revenue in Plasmid DNA CDMO Business (2020-2025)
11.19.5 PlasmidFactory Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Plasmid DNA CDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of GMP Grade Plasmid DNA
Table 3. Key Players of Non-GMP Grade Plasmid DNA
Table 4. Global Plasmid DNA CDMO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Plasmid DNA CDMO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Plasmid DNA CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Plasmid DNA CDMO Market Share by Region (2020-2025)
Table 8. Global Plasmid DNA CDMO Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Plasmid DNA CDMO Market Share by Region (2026-2031)
Table 10. Plasmid DNA CDMO Market Trends
Table 11. Plasmid DNA CDMO Market Drivers
Table 12. Plasmid DNA CDMO Market Challenges
Table 13. Plasmid DNA CDMO Market Restraints
Table 14. Global Plasmid DNA CDMO Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Plasmid DNA CDMO Market Share by Players (2020-2025)
Table 16. Global Top Plasmid DNA CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasmid DNA CDMO as of 2024)
Table 17. Ranking of Global Top Plasmid DNA CDMO Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Plasmid DNA CDMO Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Plasmid DNA CDMO, Headquarters and Area Served
Table 20. Global Key Players of Plasmid DNA CDMO, Product and Application
Table 21. Global Key Players of Plasmid DNA CDMO, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Plasmid DNA CDMO Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Plasmid DNA CDMO Revenue Market Share by Type (2020-2025)
Table 25. Global Plasmid DNA CDMO Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Plasmid DNA CDMO Revenue Market Share by Type (2026-2031)
Table 27. Global Plasmid DNA CDMO Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Plasmid DNA CDMO Revenue Market Share by Application (2020-2025)
Table 29. Global Plasmid DNA CDMO Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Plasmid DNA CDMO Revenue Market Share by Application (2026-2031)
Table 31. North America Plasmid DNA CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Plasmid DNA CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Plasmid DNA CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Plasmid DNA CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Plasmid DNA CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Plasmid DNA CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Plasmid DNA CDMO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Plasmid DNA CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Plasmid DNA CDMO Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Plasmid DNA CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Plasmid DNA CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Plasmid DNA CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Plasmid DNA CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Plasmid DNA CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Plasmid DNA CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 46. GenScript ProBio Company Details
Table 47. GenScript ProBio Business Overview
Table 48. GenScript ProBio Plasmid DNA CDMO Product
Table 49. GenScript ProBio Revenue in Plasmid DNA CDMO Business (2020-2025) & (US$ Million)
Table 50. GenScript ProBio Recent Development
Table 51. Biovian Company Details
Table 52. Biovian Business Overview
Table 53. Biovian Plasmid DNA CDMO Product
Table 54. Biovian Revenue in Plasmid DNA CDMO Business (2020-2025) & (US$ Million)
Table 55. Biovian Recent Development
Table 56. Biomay Company Details
Table 57. Biomay Business Overview
Table 58. Biomay Plasmid DNA CDMO Product
Table 59. Biomay Revenue in Plasmid DNA CDMO Business (2020-2025) & (US$ Million)
Table 60. Biomay Recent Development
Table 61. VGXI Company Details
Table 62. VGXI Business Overview
Table 63. VGXI Plasmid DNA CDMO Product
Table 64. VGXI Revenue in Plasmid DNA CDMO Business (2020-2025) & (US$ Million)
Table 65. VGXI Recent Development
Table 66. Esco Aster Company Details
Table 67. Esco Aster Business Overview
Table 68. Esco Aster Plasmid DNA CDMO Product
Table 69. Esco Aster Revenue in Plasmid DNA CDMO Business (2020-2025) & (US$ Million)
Table 70. Esco Aster Recent Development
Table 71. Catalent Company Details
Table 72. Catalent Business Overview
Table 73. Catalent Plasmid DNA CDMO Product
Table 74. Catalent Revenue in Plasmid DNA CDMO Business (2020-2025) & (US$ Million)
Table 75. Catalent Recent Development
Table 76. Richter-Helm BioLogics Company Details
Table 77. Richter-Helm BioLogics Business Overview
Table 78. Richter-Helm BioLogics Plasmid DNA CDMO Product
Table 79. Richter-Helm BioLogics Revenue in Plasmid DNA CDMO Business (2020-2025) & (US$ Million)
Table 80. Richter-Helm BioLogics Recent Development
Table 81. Cytovance Biologics Company Details
Table 82. Cytovance Biologics Business Overview
Table 83. Cytovance Biologics Plasmid DNA CDMO Product
Table 84. Cytovance Biologics Revenue in Plasmid DNA CDMO Business (2020-2025) & (US$ Million)
Table 85. Cytovance Biologics Recent Development
Table 86. Cobra Biologics Company Details
Table 87. Cobra Biologics Business Overview
Table 88. Cobra Biologics Plasmid DNA CDMO Product
Table 89. Cobra Biologics Revenue in Plasmid DNA CDMO Business (2020-2025) & (US$ Million)
Table 90. Cobra Biologics Recent Development
Table 91. Obiosh Company Details
Table 92. Obiosh Business Overview
Table 93. Obiosh Plasmid DNA CDMO Product
Table 94. Obiosh Revenue in Plasmid DNA CDMO Business (2020-2025) & (US$ Million)
Table 95. Obiosh Recent Development
Table 96. Thermo Fisher Company Details
Table 97. Thermo Fisher Business Overview
Table 98. Thermo Fisher Plasmid DNA CDMO Product
Table 99. Thermo Fisher Revenue in Plasmid DNA CDMO Business (2020-2025) & (US$ Million)
Table 100. Thermo Fisher Recent Development
Table 101. Aldevron(Danaher) Company Details
Table 102. Aldevron(Danaher) Business Overview
Table 103. Aldevron(Danaher) Plasmid DNA CDMO Product
Table 104. Aldevron(Danaher) Revenue in Plasmid DNA CDMO Business (2020-2025) & (US$ Million)
Table 105. Aldevron(Danaher) Recent Development
Table 106. Charles River Laboratories Company Details
Table 107. Charles River Laboratories Business Overview
Table 108. Charles River Laboratories Plasmid DNA CDMO Product
Table 109. Charles River Laboratories Revenue in Plasmid DNA CDMO Business (2020-2025) & (US$ Million)
Table 110. Charles River Laboratories Recent Development
Table 111. WuXi AppTec Company Details
Table 112. WuXi AppTec Business Overview
Table 113. WuXi AppTec Plasmid DNA CDMO Product
Table 114. WuXi AppTec Revenue in Plasmid DNA CDMO Business (2020-2025) & (US$ Million)
Table 115. WuXi AppTec Recent Development
Table 116. AGC Biologics Company Details
Table 117. AGC Biologics Business Overview
Table 118. AGC Biologics Plasmid DNA CDMO Product
Table 119. AGC Biologics Revenue in Plasmid DNA CDMO Business (2020-2025) & (US$ Million)
Table 120. AGC Biologics Recent Development
Table 121. AcuraBio Company Details
Table 122. AcuraBio Business Overview
Table 123. AcuraBio Plasmid DNA CDMO Product
Table 124. AcuraBio Revenue in Plasmid DNA CDMO Business (2020-2025) & (US$ Million)
Table 125. AcuraBio Recent Development
Table 126. GENE Chem Company Details
Table 127. GENE Chem Business Overview
Table 128. GENE Chem Plasmid DNA CDMO Product
Table 129. GENE Chem Revenue in Plasmid DNA CDMO Business (2020-2025) & (US$ Million)
Table 130. GENE Chem Recent Development
Table 131. Eurogentec Company Details
Table 132. Eurogentec Business Overview
Table 133. Eurogentec Plasmid DNA CDMO Product
Table 134. Eurogentec Revenue in Plasmid DNA CDMO Business (2020-2025) & (US$ Million)
Table 135. Eurogentec Recent Development
Table 136. PlasmidFactory Company Details
Table 137. PlasmidFactory Business Overview
Table 138. PlasmidFactory Plasmid DNA CDMO Product
Table 139. PlasmidFactory Revenue in Plasmid DNA CDMO Business (2020-2025) & (US$ Million)
Table 140. PlasmidFactory Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
Table 144. Authors List of This Report


List of Figures
Figure 1. Plasmid DNA CDMO Picture
Figure 2. Global Plasmid DNA CDMO Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Plasmid DNA CDMO Market Share by Type: 2024 VS 2031
Figure 4. GMP Grade Plasmid DNA Features
Figure 5. Non-GMP Grade Plasmid DNA Features
Figure 6. Global Plasmid DNA CDMO Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Plasmid DNA CDMO Market Share by Application: 2024 VS 2031
Figure 8. DNA Vaccines Case Studies
Figure 9. Gene Therapy Case Studies
Figure 10. Immunotherapy Case Studies
Figure 11. Others Case Studies
Figure 12. Plasmid DNA CDMO Report Years Considered
Figure 13. Global Plasmid DNA CDMO Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Plasmid DNA CDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Plasmid DNA CDMO Market Share by Region: 2024 VS 2031
Figure 16. Global Plasmid DNA CDMO Market Share by Players in 2024
Figure 17. Global Top Plasmid DNA CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasmid DNA CDMO as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Plasmid DNA CDMO Revenue in 2024
Figure 19. North America Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Plasmid DNA CDMO Market Share by Country (2020-2031)
Figure 21. United States Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Plasmid DNA CDMO Market Share by Country (2020-2031)
Figure 25. Germany Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Plasmid DNA CDMO Market Share by Region (2020-2031)
Figure 33. China Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Plasmid DNA CDMO Market Share by Country (2020-2031)
Figure 41. Mexico Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Plasmid DNA CDMO Market Share by Country (2020-2031)
Figure 45. Turkey Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. GenScript ProBio Revenue Growth Rate in Plasmid DNA CDMO Business (2020-2025)
Figure 49. Biovian Revenue Growth Rate in Plasmid DNA CDMO Business (2020-2025)
Figure 50. Biomay Revenue Growth Rate in Plasmid DNA CDMO Business (2020-2025)
Figure 51. VGXI Revenue Growth Rate in Plasmid DNA CDMO Business (2020-2025)
Figure 52. Esco Aster Revenue Growth Rate in Plasmid DNA CDMO Business (2020-2025)
Figure 53. Catalent Revenue Growth Rate in Plasmid DNA CDMO Business (2020-2025)
Figure 54. Richter-Helm BioLogics Revenue Growth Rate in Plasmid DNA CDMO Business (2020-2025)
Figure 55. Cytovance Biologics Revenue Growth Rate in Plasmid DNA CDMO Business (2020-2025)
Figure 56. Cobra Biologics Revenue Growth Rate in Plasmid DNA CDMO Business (2020-2025)
Figure 57. Obiosh Revenue Growth Rate in Plasmid DNA CDMO Business (2020-2025)
Figure 58. Thermo Fisher Revenue Growth Rate in Plasmid DNA CDMO Business (2020-2025)
Figure 59. Aldevron(Danaher) Revenue Growth Rate in Plasmid DNA CDMO Business (2020-2025)
Figure 60. Charles River Laboratories Revenue Growth Rate in Plasmid DNA CDMO Business (2020-2025)
Figure 61. WuXi AppTec Revenue Growth Rate in Plasmid DNA CDMO Business (2020-2025)
Figure 62. AGC Biologics Revenue Growth Rate in Plasmid DNA CDMO Business (2020-2025)
Figure 63. AcuraBio Revenue Growth Rate in Plasmid DNA CDMO Business (2020-2025)
Figure 64. GENE Chem Revenue Growth Rate in Plasmid DNA CDMO Business (2020-2025)
Figure 65. Eurogentec Revenue Growth Rate in Plasmid DNA CDMO Business (2020-2025)
Figure 66. PlasmidFactory Revenue Growth Rate in Plasmid DNA CDMO Business (2020-2025)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies